Axsome's depression drug enters competitive market after U.S. approval

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/10/2026

1. CSQR
2. B
3. SPY
4. RHP
5. STDN
6. IPH
7. TTWO
8. IPHA
9. TZOO
10. HPE

Go back to Axsome's depression drug enters competitive market after U.S. approval
(NASDAQ: AXSM) Delayed: 212.74 --0 (-0%)
Previous Close $212.74    52 Week High $15.74 
Open $212.74    52 Week Low $5.37 
Day High $212.74    P/E N/A 
Day Low $212.74    EPS $0.00 
Volume 8,648